BUY Divi's Laboratories Limited — Sachin Janardan Sarvade, IDBI Capital Markets and Securities
bySachin Janardan Sarvade, IDBI Capital Markets and SecuritiesHorizon: NA (inferred Swing (≤2wk))12 Aug 2026via NDTV Profit (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1500% Dividend Bonanza! Pharma Stock In Spotlight After Mega Payout; Record Date Announced
NewsGoogle News·19 Aug · 5d ago
2 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days
Advisor consensus · same horizon·20 Aug · 5d ago
1 advisor has an active short-term BUY call on this stock, issued in the last 14 days
Advisor consensus · adjacent horizon·18 Aug · 1w ago
Divi's Laboratories posts 65% PAT surge in Q1FY27 on strong revenue growth
NewsGoogle News·6 Aug · 3w ago
Divi's Labs Q1 Results: Profit Jumps 65.5%, Revenue Up 28% - Key Numbers
NewsNdtv-Profit·1 Aug · 3w ago
Nifty 24,500 पर फिसला, Divi's, MCX और Eternal पर रखें नज़र!
NewsGoogle News·12 Aug · 2w ago
Divi’s Laboratories Posts Q1 FY27 Earnings Call Transcript for Investors
NewsGoogle News·6 Aug · 3w ago
Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
NSE · Outcome of Board Meeting·1 Aug · 3w ago
Q1 results today: Divi's Labs, Muthoot Finance, APL Apollo among over 30 companies set to announce Q1 earnings
NewsLivemint·1 Aug · 3w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Divi's Laboratories
- BUY — Ashish Bahety, Profitmart Securities22 Oct 2026 · Same day · target ₹9,350 · SL hit
- SELL — Prakash Gaba14 Oct 2026 · ~2 weeks · target ₹8,750 · SL hit
- SELL — Mehul Kothari, Anand Rathi14 Oct 2026 · ~2 weeks · target ₹8,400 · Active
- BUY — Kavita Jain, Arihant Capital Markets6 Oct 2026 · Next day · target ₹9,750 · Expired
- BUY — Chandan Taparia, Motilal Oswal24 Sept 2026 · ~2 weeks · target ₹10,000 · SL hit
More from Sachin Janardan Sarvade, IDBI Capital Markets and Securities
- SELL Nippon Life India Asset Management23 Oct 2026 · ~2 weeks · target ₹800 · Active
- SELL Swiggy23 Oct 2026 · ~2 weeks · target ₹150 · Active
- BUY The Indian Hotels Company23 Oct 2026 · ~2 weeks · target ₹950 · Active
- BUY CRISIL23 Oct 2026 · ~2 weeks · target ₹5,735 · Active
- BUY Mangalore Refinery and Petrochemicals19 Oct 2026 · ~2 weeks · target ₹218 · Active

